Psychometric evaluation of the Adelphi Adherence Questionnaire ( <scp>ADAQ</scp> ©) in a type 2 diabetes mellitus population as a new measure of adherence and the complex factors influencing adherence in routine care
The ADAQ shows strong construct validity and high internal consistency reliability within a heterogenous T2DM population with negligible DIF between sub-groups. Future work should focus on test-retest reliability and detecting change over time.
Authors
- Jonathan D. Comins (ORCID: https://orcid.org/0000-0002-8284-114X)
- Tariq Halasa (ORCID: https://orcid.org/0000-0003-1112-0254)
- James Piercy (ORCID: https://orcid.org/0000-0001-7015-1021)
- Jan Štochl (ORCID: https://orcid.org/0000-0002-9693-9930)
- Victoria Higgins (ORCID: https://orcid.org/0000-0002-3901-7390)
- Thaís Rocha (ORCID: https://orcid.org/0000-0003-0113-6877)
- Nathan A. Clarke (ORCID: https://orcid.org/0000-0002-8636-1872)
- Rob Arbuckle (ORCID: https://orcid.org/0000-0003-0345-2523)
- Kamlesh K. Khunti (ORCID: https://orcid.org/0000-0003-2343-7099)
- Daniel Green
Institutions
- University of Leicester (GB)
- Novo Nordisk (Denmark) (DK)
- Charles University (CZ)
- Adelphi Group (United Kingdom) (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1111/dom.16551
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk